Overview
Location
France, Ile-de-France
Employees
11-50
Total raised
$22.23M
Founded date
2014
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jul 10, 2015 | Series A round | $2.23M |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 10, 2024 | Paris-based baCta secures €3.3 million to revolutionize natural rubber production | baCta, a startup making biosynthetic carbon-negative natural rubber produced using engineered microorganisms and renewable feedstocks, has successfully raised €3.3 millions in pre-seed funding. The round was led by OVNI Capital, and with pa... |
| Jul 10, 2024 | Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut | PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo has demonstrated it was possible to genetically modify bacteria with nearly 100% efficiency directly in the gut of animals. This work provides scientists... |
| Sep 26, 2017 | Khosla Ventures makes first investment in France, leads $18 million round in Eligo Bioscience | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! With resistance to antibiotics growing in the U.S... |
| Sep 26, 2017 | Eligo Bioscience raises $20 million to target the microbiome more precisely | French startup Eligo Bioscience just raised $20 million to develop next-gen biotherapeutics. Khosla Ventures is leading the round. This is also Khosla Ventures’ first investment in a French startup. Existing investor Seventure Partners is a... |
| Sep 26, 2017 | Term Sheet — Tuesday, September 26 | FRESH FUNDING Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop Before Sequoia partner Pat Grady committed to the investment, he asked Cancel about whether he was planning to exit ... |
| Sep 26, 2017 | Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome | Eligo Bioscience, the French microbiome company developing drugs to prevent and treat bacteria-associated diseases, has secured a $20 million Series A round of financing from... |
| Sep 26, 2017 | Paris-based Eligo Bioscience secures $20 million to bring Precision Medicine to the Microbiome | Eligo Bioscience, the French microbiome startup developing drugs to prevent and treat bacteria-associated diseases, has secured a $20 million in a Series A funding round from Khosla Ventures and Seventure Partners, including a $2 million aw... |
| Sep 26, 2017 | Eligo Bioscience Secures $20M in Series A Financing | Eligo Bioscience, a Paris, France-based microbiome company developing drugs to prevent and treat bacteria-associated diseases, secured $20m in Series A round of financing. Backers included Khosla Ventures and Seventure Partners, including a... |
| Sep 26, 2017 | French biotech company Eligo raises $20 million in Series A funding | Eligo Bioscience, a biotech company based in France, has raised a $20 million Series A round from Khosla Ventures and Seventure Partners together with a $2 million award from Worldwide Innovation Challenge. Eligo is developing a biotherapeu... |
Show more
Reviews 0
FAQ about Eligo Bioscience
When was Eligo Bioscience founded?
Eligo Bioscience was founded in 2014.
How much funding has Eligo Bioscience raised?
Eligo Bioscience has raised $22.23M in total across 2 funding rounds.
What funding rounds has Eligo Bioscience raised?
Parsers VC lists 2 funding rounds of Eligo Bioscience, among them a Series A round of $2.23M on Jul 10, 2015.
What has the press written about Eligo Bioscience?
Parsers VC has collected 12 articles mentioning Eligo Bioscience, among them “Paris-based baCta secures €3.3 million to revolutionize natural rubber production” (Oct 10, 2024) and “Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut” (Jul 10, 2024).
Is Eligo Bioscience still active?
Yes, Eligo Bioscience is active; its latest activity on Parsers VC dates from May 13, 2025.